Updates on capivasertib, belzutifan, talquetamab, & durvalumab
Jun 18, 2026 - 00:19:32
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsPivekimab sunirine, a novel CD-123 antibody drug conjugate is approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Also, what the heck is BPDCN? Check out the Oncology Insights Newsletter:
Pivekimab sunirine is an episode from OncoPharm by OncoPharmPod. Pivekimab sunirine, a novel CD-123 antibody drug conjugate is approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Also, what the heck is BPDCN? Check out the On...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published May 28, 2026, 00:13:49 long, audio available.
Continue listening to more episodes from OncoPharm.
Jun 18, 2026 - 00:19:32
Jun 11, 2026 - 00:25:38
May 21, 2026 - 00:13:45
May 14, 2026 - 00:09:59
May 7, 2026 - 00:11:35
Apr 30, 2026 - 00:12:41
Apr 23, 2026 - 00:13:56
Apr 16, 2026 - 00:13:24